Alligator Bioscience: Alligator Bioscience AB Reports Financial Results for Q1 2025 and Provides a Business Update
LUND, SE / ACCESS Newswire / April 24, 2025 / Alligator Bioscience (STO:ATORX)24-month data from OPTIMIZE-1 show 29.4% survival rate for mitazalimab-three times higher than chemotherapy aloneFDA al...
Read full article »
Alligator is a Sweden-based biotechnology firm that develops and commercializes antibody-based immunotherapies for the treatment of cancer.
Read more